Efavirenz dose reduction to 200 mg once daily in a patient treated with rifampicin.

Fulltext present in this item

Fulltext: 80842.pdf

Format: PDF

Description: publisher's version

Embargo: until further notice

Title:	Efavirenz dose reduction to 200 mg once daily in a patient treated with rifampicin.
Author(s):	Luin, M. van ; Brouwer, A.E. ; Ven, A.J.A.M. van der ; Lange, W. de; Schaik, R.H. van; Burger, D.M.
Publication year:	2009
Source:	Aids, vol. 23, iss. 6, (2009), pp. 742-744
ISSN:	0269-9370
DOI:	https://doi.org/10.1097/QAD.0b013e32832914a3
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : http://hdl.handle.net/2066/80842
Display more details
Subject:	N4i 3: Poverty-related infectious diseases NCEBP 13: Infectious diseases and international health NCMLS 1: Infection and autoimmunity
Organization:	Clinical Pharmacy Internal Medicine
Journal title:	Aids
Volume:	vol. 23
Issue:	iss. 6
Page start:	p. 742
Page end:	p. 744

Faculty of Medical Sciences [64633]
Electronic publications [73424]
Freely accessible full text publications plus those not yet available due to embargo
Academic publications [163886]
Academic output Radboud University